Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

IQVIA logoIQVIA IQV

The company said revenue for Q2 2025 was $4,017 million, up 5.3% year over year on a reported basis (3.6% at constant currency). GAAP net income was $266 million, and GAAP diluted earnings per share was $1.54.

8-KResults of Operations and Financial ConditionFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said revenue for Q2 2025 was $4,017 million, up 5.3% year over year on a reported basis (3.6% at constant currency). GAAP net income was $266 million, and GAAP diluted earnings per share was $1.54.

  2. IQVIA said R&DS contracted backlog stood at $32.1 billion as of June 30, 2025, up 5.1% year over year. It said second-quarter net new bookings for Q2 were $2.5 billion, with a book-to-bill ratio of 1.12x.

  3. The company said operating cash flow for Q2 was $443 million and free cash flow was $292 million. In the same quarter, it repurchased $607 million of common stock, and cumulative share repurchases for the first half were $1,032 million.

  4. The company presented its full-year 2025 guidance, with revenue of $16,100 million to $16,300 million, Adjusted EBITDA of $3,750 million to $3,825 million, and Adjusted Diluted Earnings per Share of $11.75 to $12.05. The company said this guidance assumes foreign currency exchange rates as of July 21, 2025 remain in effect for the forecast period.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

QQ2 revenue of $4,017 million, net income of $266 million

The company said revenue for Q2 2025 was $4,017 million, up 5.3% year over year on a reported basis (3.6% at constant currency). GAAP net income was $266 million, and GAAP diluted earnings per share was $1.54.

Source · Based on the filing body and exhibits

R&DS backlog $32.1 billion, Q2 book-to-bill 1.12x

IQVIA said R&DS contracted backlog stood at $32.1 billion as of June 30, 2025, up 5.1% year over year. It said second-quarter net new bookings for Q2 were $2.5 billion, with a book-to-bill ratio of 1.12x.

Source · Based on the filing body and exhibits

Q2 free cash flow $292 million, share buybacks $607 million

The company said operating cash flow for Q2 was $443 million and free cash flow was $292 million. In the same quarter, it repurchased $607 million of common stock, and cumulative share repurchases for the first half were $1,032 million.

Source · Based on the filing body and exhibits

Full-year outlook: revenue $16,100 million to $16,300 million

The company presented its full-year 2025 guidance, with revenue of $16,100 million to $16,300 million, Adjusted EBITDA of $3,750 million to $3,825 million, and Adjusted Diluted Earnings per Share of $11.75 to $12.05. The company said this guidance assumes foreign currency exchange rates as of July 21, 2025 remain in effect for the forecast period.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.